Albion Financial Group’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $8.79M | Buy |
24,267
+171
| +0.7% | +$58.5K | 0.51% | 48 |
|
|
2026
Q1 | $8.48M | Sell |
24,096
-185
| -0.8% | -$66K | 0.55% | 46 |
|
|
2025
Q4 | $7.95M | Sell |
24,281
-2,357
| -9% | -$748K | 0.49% | 47 |
|
|
2025
Q3 | $7.52M | Buy |
26,638
+37
| +0.1% | +$10.7K | 0.45% | 54 |
|
|
2025
Q2 | $7.43M | Sell |
26,601
-41
| -0.2% | -$11.6K | 0.49% | 52 |
|
|
2025
Q1 | $8.3M | Buy |
26,642
+319
| +1% | +$94.2K | 0.59% | 45 |
|
|
2024
Q4 | $6.86M | Sell |
26,323
-359
| -1% | -$107K | 0.47% | 48 |
|
|
2024
Q3 | $8.6M | Buy |
26,682
+575
| +2% | +$188K | 0.6% | 43 |
|
|
2024
Q2 | $8.16M | Buy |
26,107
+171
| +0.7% | +$50.2K | 0.61% | 36 |
|
|
2024
Q1 | $7.37M | Buy |
25,936
+131
| +0.5% | +$38.3K | 0.57% | 41 |
|
|
2023
Q4 | $7.43M | Sell |
25,805
-178
| -0.7% | -$48.5K | 0.61% | 38 |
|
|
2023
Q3 | $6.98M | Buy |
25,983
+1,632
| +7% | +$407K | 0.64% | 35 |
|
|
2023
Q2 | $5.41M | Sell |
24,351
-554
| -2% | -$129K | 0.47% | 45 |
|
|
2023
Q1 | $6.02M | Sell |
24,905
-179
| -0.7% | -$43.9K | 0.55% | 41 |
|
|
2022
Q4 | $6.59M | Buy |
25,084
+24
| +0.1% | +$6.43K | 0.64% | 37 |
|
|
2022
Q3 | $5.65M | Sell |
25,060
-8
| -0% | -$1.94K | 0.58% | 40 |
|
|
2022
Q2 | $6.1M | Buy |
25,068
+62
| +0.2% | +$15.2K | 0.6% | 39 |
|
|
2022
Q1 | $6.05M | Sell |
25,006
-33
| -0.1% | -$7.58K | 0.51% | 44 |
|
|
2021
Q4 | $5.63M | Buy |
25,039
+652
| +3% | +$138K | 0.45% | 53 |
|
|
2021
Q3 | $5.19M | Sell |
24,387
-110
| -0.4% | -$25.3K | 0.45% | 49 |
|
|
2021
Q2 | $5.97M | Buy |
+24,497
| New | +$6.03M | 0.52% | 42 |
|
|
2020
Q4 | $5.15M | Buy |
22,398
+623
| +3% | +$144K | 0.5% | 45 |
|
|
2020
Q3 | $5.53M | Buy |
21,775
+403
| +2% | +$99.8K | 0.6% | 44 |
|
|
2020
Q2 | $5.04M | Buy |
21,372
+1,166
| +6% | +$266K | 0.59% | 41 |
|
|
2020
Q1 | $4.1M | Buy |
20,206
+729
| +4% | +$159K | 0.6% | 40 |
|
|
2019
Q4 | $4.7M | Buy |
19,477
+286
| +1% | +$63K | 0.56% | 42 |
|
|
2019
Q3 | $3.71M | Buy |
19,191
+111
| +0.6% | +$21.3K | 0.48% | 51 |
|
|
2019
Q2 | $3.52M | Buy |
19,080
+2,066
| +12% | +$370K | 0.45% | 50 |
|
|
2019
Q1 | $3.23M | Buy |
17,014
+2,961
| +21% | +$565K | 0.44% | 50 |
|
|
2018
Q4 | $2.74M | Buy |
14,053
+1,340
| +11% | +$261K | 0.43% | 51 |
|
|
2018
Q3 | $2.63M | Buy |
12,713
+551
| +5% | +$109K | 0.36% | 58 |
|
|
2018
Q2 | $2.25M | Buy |
12,162
+2,972
| +32% | +$526K | 0.32% | 62 |
|
|
2018
Q1 | $1.57M | Buy |
9,190
+6,575
| +251% | +$1.21M | 0.24% | 72 |
|
|
2017
Q4 | $455K | Buy |
2,615
+895
| +52% | +$158K | 0.07% | 133 |
|
|
2017
Q3 | $321K | Hold |
1,720
| – | – | 0.05% | 153 |
|
|
2017
Q2 | $296K | Buy |
+1,720
| New | +$280K | 0.05% | 157 |
|
Other funds holding AMGN
SP
SMDAM
CRM
SW
Albion Financial Group's AMGN Position: Q2 2026 in Review
Albion Financial Group increased its Amgen (AMGN) stake by 0.71% in Q2 2026, buying an estimated $58.5K and bringing the position to 24,267 shares worth $8.79M. The position accounts for 0.51% of the portfolio, ranked #48.
Albion Financial Group first reported a position in AMGN in Q2 2017 and has held it in 36 quarters since. 836 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Albion Financial Group held 24,267 shares of Amgen worth $8.79M as of Q2 2026.
- Albion Financial Group bought 171 Amgen shares in Q2 2026, an estimated $58.5K.
- Amgen made up 0.51% of Albion Financial Group's portfolio in Q2 2026, its #48 holding.
- Albion Financial Group first reported a position in Amgen in Q2 2017 and has held it in 36 quarters since.
- 836 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Albion Financial Group's 13F filing for Q2 2026, filed 22 Jul 2026.